(6R,7R)-7-[[(2Z)-2-(2-amino-5-chloro-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-8-oxo-3-[(E)-[2-oxo-1-[(3R)-pyrrolidin-3-yl]pyrrolidin-3-ylidene]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 内酰胺类
• 英文名称: (6R,7R)-7-[[(2Z)-2-(2-amino-5-chloro-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-8-oxo-3-[(E)-[2-oxo-1-[(3R)-pyrrolidin-3-yl]pyrrolidin-3-ylidene]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• 化学式: C₂₁H₂₂ClN₇O₆S₂
• 分子量: 568.0
• InChiKey: JYYDKDHUEQYABA-UXOHZIGZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.3
• 重原子数：
  37
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  244
• 氢给体数：
  5
• 氢受体数：
  12

文献信息

• [EN] VINYLPYRROLIDINONE DERIVATIVES WITH SUBSTITUTED THIAZOLE RING<br/>[FR] DERIVES DE VINYLPYRROLIDINONE A CYCLE THIAZOLE SUBSTITUE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2001004127A1

  公开（公告）日：2001-01-18

  The invention is concerned with cephalosporin derivatives of general formula (I) wherein X is chlorine, bromine, fluorine, trifluoromethyl, methyl, carboxy or hydroximethyl; R1 is hydrogen or lower alkanoyl; R2 is hydrogen or an in vivo cleavable group; Y1 is a group -CHR3-; Y2 is one of the groups -CHR?3-, -CHR3-CHR3¿- and -CHOH-CHR3-; R3 is the same or different and selected from hydrogen, hydroxy-lower alkyl and amino-lower alkyl, and readily hydrolyzable ester of compounds of formula I, as well as pharmaceutically acceptable salts of said compounds of formula I and of their esters and salts, with the manufacture of compounds aforesaid; and with their use as pharmaceutically active substances in the treatment and prophylaxis of infectious diseases.